Hewlett Packard Enterprise is nearing a deal to sell its software division to Britain’s Micro Focus International, a person familiar with the matter said on Wednesday, as the U.S. company focuses on serving large corporate customers.
The sale would help HPE CEO Meg Whitman execute a plan to shift HPE’s strategy to a few key areas such as networking, storage, and technology services since the company separated last year from computer and printer maker HP Inc.
HPE had been in talks with private equity firms to sell the unit for between $8 billion and $10 billion. HPE was reportedly in talks earlier this week with buyout firm Thoma Bravo to sell its software division. At the time, HPE had received offers for the software unit of as much as $7.5 billion in a sale process managed by investment bank Goldman Sachs Group.
The sale to Micro Focus, a multinational software company, is expected to be announced along with HPE’s latest quarterly earnings later on Wednesday, the source said. The source asked not to be identified because the deal is not yet public. HPE and Micro Focus declined to comment on the deal, which was first reported by Sky News.
Full Content: Fortune
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Live Nation Under Criminal Antitrust Investigation Over Pandemic-Era Refund Policies
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas